Tiffini Pearson-Callion

Tiffini Pearson-Callion has extensive experience in quality control within the biopharmaceutical sector. Currently serving as the QC Raw Materials Manager and previously as the QC Microbiology Manager at CRISPR Therapeutics since July 2021, Tiffini has demonstrated expertise in managing quality processes. Prior roles include QC Lead Microbiology/Raw Materials at Rentschler Biopharma SE from June 2019 to December 2021, and QC Micro Analyst II at Baxter from December 2013 to December 2021. Additionally, Tiffini has experience as a QC Chemist specializing in stability at Johnson Matthey Pharma Services for a brief period in late 2011 to early 2012.